Geoffrey is an APS at CHARM, with scientific experience utilising structure based drug design for multiple target classes that cross GPCRs, and oncogenic associated kinases, transcription factors, and nuclear hormone receptors. He joins CHARM after gaining experience at leading biotech such as Sosei Heptares, and CRUK Therapeutic Discovery Laboratories.